An Evolution in IBD Hatchery Vaccination
MB-1® live attenuated vaccine for Infectious Bursal Disease, was developed from the M.B. strain, adapted for in-ovo or subcutaneous injection in the hatchery.
Efficacy
The MB-1 vaccine provides, on average, 4-day earlier onset of immunity compared to other hatchery vaccines.
Convenience
The MB-1 vaccine adjusts its release to the individual titer of IBD Maternally Derived Antibodies generating the desired immune response in every chick at the optimal time.
Safety
The MB-1 vaccine is safe and does not interfere with the immune response to other vaccines.
Why do we vaccinate against Gumboro disease (IBD)?
Juan Carlos Valladares
Poultry Vaccines Technical Manager
Is the M.B. strain safe enough
to be used routinely?
Eva Hunka
Biological Business Manager Brazil
What is the role of MDAs in early
protection against IBD - especially
when using hatchery vaccination?
Charles Costello
Poultry Technical and Marketing Director
How do we know if an IBD vaccine really works?
Udi Ashash
Director; Poultry Vaccines Technical Services, Vaccines
Why do we vaccinate for Gumboro disease?
Wojciech Hodorowicz
Poultry Diseases Specialist
As an intermediate strain of Gumboro, how is the M.B. strain safe enough to be used routinely?
Pablo Sansalone
Poultry Vaccines Technical Manager
Why do we vaccinate against Gumboro disease (IBD)?
Juan Carlos Valladares
Poultry Vaccines Technical Manager
Is the M.B. strain safe enough
to be used routinely?
Eva Hunka
Biological Business Manager Brazil
What is the role of MDAs in early
protection against IBD - especially
when using hatchery vaccination?
Charles Costello
Poultry Technical and Marketing Director
How do we know if an IBD vaccine really works?
Udi Ashash
Director; Poultry Vaccines Technical Services, Vaccines
Why do we vaccinate for Gumboro disease?
Wojciech Hodorowicz
Poultry Diseases Specialist
As an intermediate strain of Gumboro, how is the M.B. strain safe enough to be used routinely?
Pablo Sansalone
Poultry Vaccines Technical Manager
MB-1 Mode of Action
How does MB-1 differ from other IBD vaccines?
- The MB-1 vaccine is proven to be safe for in-ovo or day-old subcutaneous administration with the correct balance to stimulate an early Onset Of Immunity (OOI)
- The MB-1 vaccine adjusts its release to the individual titers of Maternally Derived Antibodies.